Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Dose of Escalation Design to Investigate the Therapeutic Role of RNA Fragments in the Protection of Platelet Production During Chemotherapy

NCT01163110 is registered in ClinicalTrials.gov with Midwestern Regional Medical Center as lead sponsor.

NCT NCT01163110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01163110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Dose of Escalation Design to Investigate the Therapeutic Role of RNA Fragments in the Protection of Platelet Production During Chemotherapy
Lead sponsor
Midwestern Regional Medical Center
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2004
Completion date
June 30, 2007
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasm, thrombocytopenia